A prospective, open-label, longitudinal, phase IV study to evaluate the antihypertensive efficacy of free versus fixed-combination of perindopril and amlodipine.

Trial Profile

A prospective, open-label, longitudinal, phase IV study to evaluate the antihypertensive efficacy of free versus fixed-combination of perindopril and amlodipine.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2016

At a glance

  • Drugs Perindopril/amlodipine (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms SYMBIO Trial
  • Most Recent Events

    • 25 Apr 2016 Results of subgroup analysis published in the Clinical Drug Investigation.
    • 21 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top